Do we want to change something or is everything okay? .... that not everything in the company is running smoothly. P has done a great job in the medical field. And capital is certainly needed too. The conditions of the financial business at that time were the worst imaginable. I firmly believe that this setback to 1.20 should not have been; the corporate action should have taken place at a significantly higher price.
But not only that. I get the impression that the price has been manipulated (short sale) on the one hand and some "old" shareholders on the other
(including those with option rights) have sold after the lock-up period has expired.
Who sells his shares when he has the prospect that the price will be a good deal higher in a few weeks ???
The measure contributed to the uncertainty among shareholders.
If the goal is to advance Sernova with his science and medicine, then it is legitimate to ask awkward questions.
In addition to good craftsmanship, good management and top press work (financial advisor) are essential.
The whole world needs to know what's in the pipeline !!!!!!
The above points have helped us now
bob around at $ 1.50. This course level is downright ridiculous.
I hope that we will deal with us shareholders in an open, transparent and fair manner. Not only LJ wants to know how his and our capital is used.
I also sent my perceptions to Sernova by email.
The purpose of open questions is to point out grievances and, above all, to address them !!!!
W K it's not complaining, it's the courage to point out mistakes.
Otherwise what we all don't want will happen ...
We sell because we are disappointed. Then it's better to address the problems so that they can be fixed.
We shareholders should carefully formulate our smart questions, bundle them and present them at the Annual General Meeting.